Log In

Forgot Password?
Create New Account

Loading... please wait

2021 Annual Meeting | S14 - Behavioral and Cognitive Neurology

Monday 04/19/21
02:00 PM - 03:00 PM EDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
Kimiko Domoto-Reilly, MD, Victor W. Henderson, MD, FAAN
Aging, Dementia, and Behavioral Neurology
1.00 CME credit

Program Materials Program Evaluations

Event Timeline
02:00 PM - 02:08 PM EDT Abstract 001 - Cortical Microstructure in Primary Progressive Aphasia: a multicenter study
Ignacio Illan-Gala, Sr., MD, PhD
02:08 PM - 02:16 PM EDT Abstract 002 - Shorter Survival in Right Hemisphere-Predominant Logopenic Progressive Aphasia
Marina Buciuc, MD
02:16 PM - 02:24 PM EDT Q&A Questions and Answers
02:24 PM - 02:32 PM EDT Abstract 003 - A Highly Efficient Method for Single-Cell Electroporation in Mouse Organotypic Hippocampal Slice Culture
Amy Cheung
02:32 PM - 02:40 PM EDT Abstract 004 - Lateralization of Motor Damage Influences the Features of Cognitive Impairment in ALS.
Adriano Chio, MD, FAAN
02:40 PM - 02:48 PM EDT Abstract 005 - A different cognitive and behavioral profile in ALS patients with or without C9orf72 expansion
Cristina Moglia
02:48 PM - 03:00 PM EDT Q&A Questions and Answers
Faculty Disclosures
Alberto Lleo, MD Dr. Lleo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lleo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Lleo has received research support from Instituto de Salud Carlos III. The institution of Dr. Lleo has received research support from Generalitat de Calalunya (PERIS). The institution of Dr. Lleo has received research support from BBVA Foundation. The institution of Dr. Lleo has received research support from La Caixa Foundation. Dr. Lleo has received intellectual property interests from a discovery or technology relating to health care.
Nha Trang Thu Pham Nha Trang Thu Pham has received personal compensation for serving as an employee of Mayo Clinic.
Juan Fortea, MD, PhD Dr. Fortea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Fortea has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Inmune. Dr. Fortea has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Fortea has received research support from NIH. Dr. Fortea has received intellectual property interests from a discovery or technology relating to health care.
Barbara Iazzolino No disclosure on file
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
No disclosure on file
Adriano Chio, MD, FAAN Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.
Umberto Manera, MD Dr. Manera has nothing to disclose.
Howard J. Rosen, MD Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Alector that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.
Andrea Calvo, MD, PhD, FAAN Dr. Calvo has nothing to disclose.
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics.
Jennifer L. Whitwell, PhD Dr. Whitwell has nothing to disclose.
Cristina Moglia Cristina Moglia has nothing to disclose.
Val J. Lowe, MD Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Antonio Canosa Antonio Canosa has nothing to disclose.
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
Francesca Palumbo No disclosure on file
Rosario Vasta, MD Dr. Vasta has nothing to disclose.
Maura Brunetti No disclosure on file
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
Ignacio Illan-Gala, Sr., MD, PhD Dr. Illan-Gala has nothing to disclose.
Neus Falgàs Martínez Neus Falgàs Martínez has nothing to disclose.
Maria Luisa Gorno Tempini, MD, PhD The institution of Dr. Gorno Tempini has received research support from NIH.
Joseph Duffy No disclosure on file
Marina Buciuc, MD Dr. Buciuc has nothing to disclose.
Matthew Senjem Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Rafael G. Blesa, MD Dr. Blesa has nothing to disclose.
Amy Cheung Ms. Cheung has nothing to disclose.
Mary M. Machulda, PhD The institution of Dr. Machulda has received research support from NIH.
Daniel Alcolea Rodriguez Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fujirebio Europe. Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Fujirebio Europe. Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. Daniel Alcolea Rodriguez has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Nutricia. The institution of Daniel Alcolea Rodriguez has received research support from Fujirebio - Europe. Daniel Alcolea Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Victor Montal No disclosure on file
Kimiko Domoto-Reilly, MD Dr. Domoto-Reilly has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MedBridge. The institution of Dr. Domoto-Reilly has received research support from Lawson Health Research Institute. The institution of Dr. Domoto-Reilly has received research support from NIH. The institution of Dr. Domoto-Reilly has received research support from Biogen. The institution of Dr. Domoto-Reilly has received research support from Lewy Body Dementia Association. The institution of Dr. Domoto-Reilly has received research support from Garvey Institute for Brain Health Solutions. The institution of Dr. Domoto-Reilly has received research support from Cognition Therapeutics. The institution of Dr. Domoto-Reilly has received research support from Takayama Family.
Victor W. Henderson, MD, FAAN Dr. Henderson has stock in Abbott, Amgen, Roche. The institution of Dr. Henderson has received research support from NIH. The institution of Dr. Henderson has received research support from Health IQ. Dr. Henderson has received personal compensation in the range of $500-$4,999 for serving as a External advisory committee member, Alzheimer's Disease Center with University of Kansas. Dr. Henderson has a non-compensated relationship as a adjunct (honorary) professor with Aarhus University that is relevant to AAN interests or activities.